Alyeska Investment Group, L.P. 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 4:20 pm Purchase |
2025-03-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Alyeska Investment Group, L.P. | 530,000 9.990% |
530,000 (New Position) |
Filing |